Hero MotoCorp Q4 Review - Healthy Dividend Yield, Low Valuation To Limit Downside: Dolat Capital
A Hero MotoCorp Ltd. Xtreme 200R motorcycle, left, stands on display in Noida, India. (Photographer: Anindito Mukherjee/Bloomberg)

Hero MotoCorp Q4 Review - Healthy Dividend Yield, Low Valuation To Limit Downside: Dolat Capital

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Hero MotoCorp Ltd. Q4 FY21 Ebitda number beat estimates led by better product mix (higher share of Splendor and export), cost saving program (LEAP), price hike and higher spare parts revenue.

Ebitda per vehicle increased by 1% QoQ to Rs 7,700/vehicle.

We expect Q1 FY22 sales to be dampened as lockdowns across India has disrupted wedding season due to the surge in Covid-19 cases.

Resultantly, the company’s inventory is at elevated levels currently (seven to eight weeks).

Management believes recovery will be sharp from Q2, post vaccination drive.

Rural demand continues to be strong, on expectations of a normal monsoon and better Rabi harvesting.

Click on the attachment to read the full report:

Dolat Capital Hero Motocorp Q4FY21 Result update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.